Press Release

May 17, 2018

Patient Enrollment Completed in autoRIC® Trial

CellAegis Announces Completion of Patient Enrollment in Danish Investigator Sponsored Clinical Trial Using autoRIC® Device TORONTO, Canada, May 17, 2018 – CellAegis Devices Inc. (“CellAegis” or […]
April 24, 2018

CellAegis Announces First Distribution Agreement for autoRIC® in Europe

TORONTO, Canada, April 24, 2018 (GLOBE NEWSWIRE) – CellAegis Devices Inc. (“CellAegis”) a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for acute […]
April 17, 2018

CellAegis Strengthens Management Team to Support Future Growth

TORONTO, Canada, April 17, 2018 (GLOBE NEWSWIRE) – CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective […]
April 10, 2018

CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial

TORONTO, Canada, April 10, 2018 (GLOBE NEWSWIRE) – CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective […]
March 14, 2017

CellAegis Devices Announces US$9.5 Million Financing to Support Clinical and Regulatory Advancement of its autoRIC® Device

March 14, 2017 Toronto, Canada – CellAegis Devices Inc, a Toronto-based medical device company, today announced closing a US$ 9.5 million Series C financing to support […]
July 25, 2016

Peel-Halton Region Aims to minimize Damage to Heart Attack Patients

Automated non-invasive RIC therapy is the result of Canadian innovation and development Toronto, Ontario, July 25, 2016 — In Canada, there are more than 70,000 heart attacks […]
July 6, 2015

RSK Medical and CellAegis Devices partner in the Canadian Healthcare Market

RSK Medical and CellAegis Devices partner in the Canadian Health Care Market to improve outcomes for heart attack patients. RSK Medical will distribute CellAegis’ innovative Canadian […]
Get autoRIC®